Wisevoter
U.S.

Fertility Tech Investment Has Surged

Capital in the reproductive health sector has shifted toward venture-backed AI diagnostic tools and laboratory innovation.

Updated on Sept. 21, 2026 in Pregnancy

Bold vector editorial illustration of a glass Petri dish containing a stylized cellular lattice, representing fertility diagnostic technology.
PwC reports a shift in fertility market funding, with venture capital increasingly targeting AI-driven diagnostic tools rather than traditional clinic consolidation. AI Illustration. Upload story photo >

Live Poll

Should fertility benefits be a standard expectation for employee compensation packages?

A new PwC analysis reveals that fertility market investment has evolved from private equity clinic roll-ups to venture capital funding for technology. Demographic shifts in the United States, including a rise in the age of first-time mothers to 27.5 years, have fueled increased demand for fertility services.

Why it matters

As family-building timelines lengthen, enterprise employers and states are increasingly adopting fertility coverage mandates to attract talent. The sector is now focused on improving success rates through AI-driven diagnostic laboratory tools.

The global fertility market is valued at $25 billion to $35 billion, with projections suggesting it could reach $45 billion by 2030. Elective egg freezing cycles in the United States grew nearly fourfold between 2014 and 2021.

The players

PwC

This is a multinational professional services network that publishes periodic market analyses on various global industries.

The details

Private equity firms previously consolidated independent practices into regional clinic platforms, while venture capital syndicates have now backed nearly 400 funding rounds for precision diagnostics. AI models for predicting embryo implantation have reached 62.5 percent accuracy, notably outperforming the 51.9 percent average observed in human embryologist assessments.

Timeline

  1. The average age of first-time U.S. mothers was 24.9 years in 2000.

  2. Elective egg freezing cycles grew nearly 4x between 2014 and 2021.

  3. Private equity firms deployed over $14 billion into clinic roll-ups from 2020 to 2025.

  4. 25 states and Washington, D.C. enacted fertility coverage mandates by March 2026.

  5. The global fertility market is projected to reach $45 billion by 2030.

Culture Shift

This fertility market expansion follows the pattern set by the Affordable Care Act's essential health benefits framework, which continues to drive the standardization of coverage. The shift toward corporate-sponsored fertility benefits reflects a broader evolution in how U.S. employers define essential talent retention assets.

Employees at firms with 500 or more workers may gain access to expanded fertility benefits as 25 percent of these employers plan coverage updates in 2026. Individuals in 25 states and Washington, D.C. should verify their specific private insurance mandates to see how their fertility care costs may change.

The takeaway

Fertility technology is transitioning from simple clinic consolidation to data-driven diagnostic tools that aim to improve implantation success rates. Readers should review their current employer benefit packages to determine if they qualify for updated fertility coverage or elective preservation services.

Further reading

For more on evolving family-building trends, visit the Pregnancy section.

Source note: This article includes information reported by Hitconsultant.

Live Poll

Should fertility benefits be a standard expectation for employee compensation packages?